Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 7/14/2015
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 1||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Muscular weakness, Seizure, Wheelchair user
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: GARDASIL, Immunisation, D1
Diagnostic Lab Data:
CDC 'Split Type': WAES1410DEU016688
Write-up:Case was received from a physician via a company representative on 29-Oct-2014 from Sanofi Pasteur (reference # DE-1577272925-E2014-10163) on 30-OCT-2014. Case is medically confirmed and poorly documented. A 14-year-old female patient received a second dose of GARDASIL (lot-no. not reported) on an unspecified date in 2014. Fourteen days later she developed convulsions and weakness of her legs leading to the need of a wheelchair. At the time of reporting the patient was treated in a rehabilitation centre. At the time of reporting the patient had not recovered. First dose of GARDASIL was given on an unspecified date. Toleration was not reported.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166